九強生物(300406.SZ):減持期過半 於建平等四股東均未實施減持
格隆匯 10 月 23日丨九強生物(300406.SZ)公佈,持公司股份630,516股,佔公司總股本比例0.127%的高級管理人員SHENGDAN,計劃以集中競價或大宗交易等方式減持公司157,629股股份,佔公司總股本比例0.032%。持公司股份347,798股,佔公司總股本比例0.070%的高級管理人員於建平,計劃以集中競價或大宗交易等方式減持公司86,950股股份,佔公司總股本比例0.017%。持公司股份110,638股,佔公司總股本比例0.022%的高級管理人員劉偉,計劃以集中競價或大宗交易等方式減持公司27,660股股份,佔公司總股本比例0.006%。持公司股份70,702股,佔公司總股本比例0.014%的高級管理人員周明,計劃以集中競價或大宗交易等方式減持公司17,676股股份,佔公司總股本比例0.004%。
減持期過半,以上股東在此期間內均未進行減持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.